Health Policy

The FDA is advocating for the removal of the "interchangeability" label for biosimilars to simplify the [...]

FDA Commissioner Robert Califf faced intense questioning from the House Committee on Oversight and Accountability regarding [...]

The FDA has broadened the approved use of Carvykti, a CAR-T cell therapy developed by Johnson [...]

Abbott Laboratories has received U.S. FDA approval for TriClip, a heart valve repair device designed to [...]

The Centers for Medicare and Medicaid Services announced guidelines mandating explicit patient consent for medical students [...]

The Supreme Court recently deliberated on a pivotal case, Alliance for Hippocratic Medicine v. FDA, that [...]

The U.S. Food and Drug Administration (FDA) recently approved Winrevair, a new treatment developed by pharmaceutical [...]

The Texas Medical Board has released draft guidance aimed at clarifying when abortions are legally permissible [...]

The Environmental Protection Agency (EPA) has announced a comprehensive ban on all forms of asbestos in [...]

In his State of the Union address, President Joe Biden highlighted healthcare as a central priority, [...]

The Biden Administration announced continued progress in its campaign to reduce drug prices, highlighting that all [...]

The Alabama Supreme Court's recent decision to classify frozen embryos as children under the law has [...]

Colorado’s prescription drug affordability board is considering capping the cost of Amgen’s autoimmune medication Enbrel, marking [...]

In a landmark decision, the Alabama Supreme Court has ruled that embryos destroyed in a bizarre [...]

The Alliance for Women’s Health and Prevention (AWHP) has launched the “EveryBODY Covered” campaign, with support [...]

Three pharmaceutical companies—GSK, Kaléo, and Amneal—have agreed to delist several patents in response to the Federal [...]

The House Select Subcommittee on the Coronavirus Pandemic, led by Chairman Rep. Brad Wenstrup (R-Ohio), is [...]

Patients For Affordable Drugs Now (P4ADNow) has initiated a campaign against Rep. Don Davis (D-N.C.) through [...]

The U.S. Food and Drug Administration (FDA) recently approved Takeda's Eohilia, marking the introduction of the [...]

CEOs from Johnson & Johnson, Merck, and Bristol Myers Squibb testified before the Senate Health, Education, [...]

The 2025 Medicare Advantage (MA) proposals introduced by CMS indicate a cautious approach by the Biden [...]

Publicis Health has agreed to a $350 million settlement to address its involvement in the opioid [...]

The FDA is planning significant reforms to its advisory committee process, as announced by Commissioner Rob [...]

The Supreme Court is set to hear arguments on March 26 about access to the abortion [...]